PUBLIC COMPANY

$LGVNLongeveron Inc.

Miami, FL, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 2

Phase 2

laromestrocel

Alzheimer's Disease

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Longeveron Inc. jobs →

News

no news has mentioned this company yet

Active trials

phase2Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.active not recruitingn=40
phase1Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)unknownn=70
phase2Lomecel-B Effects on Alzheimer's Diseasecompletedn=50
phase2Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)unknownn=10

$LGVN

Insider activity

source: SEC Form 4

routine RSU / option mechanics (6)

Apr 1, 26tax coverAgafonova Nataliya · Chief Medical Officer13,145 sh
Apr 1, 26tax coverLocklear Lisa · Chief Financial Officer13,145 sh
Apr 1, 26tax coverBlass Devin · CTO & SVP of CMC8,633 sh
Apr 1, 26tax coverLehr Paul T · General Counsel, Secretary5,611 sh
Apr 1, 26tax coverWillard Stephen H · Chief Executive Officer4,740 sh
Mar 2, 26tax coverWillard Stephen H · Chief Executive Officer105,533 sh

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

SEC EDGAR

last refreshed 28m ago

Found something off?